Hold-rated reports

932 tickers rated Hold
Ranks this page's recent reports by score.
Duke Energy Corporation
DUK·Utilities
B ★★★Hold
Current$127.39
Target$129.06
Return+1.3%
Nov 1, 2026

Duke Energy offers durable regulated electricity earnings, an established dividend, and growing power demand, but its $103B investment program and heavy financing needs constrain free cash flow and near-term valuation upside.

Score
66
Merck & Co., Inc.
MRK·Healthcare
B ★★★Hold
Current$149.52
Target$155.04
Return+3.7%
Nov 1, 2026

Merck combines a powerful oncology franchise, substantial cash generation, and a promising drug pipeline, but its valuation and dependence on successfully replacing future KEYTRUDA revenue limit the current margin of safety.

Score
67
BrightSpring Health Services, Inc.
BTSG·Healthcare
B ★★★Hold
Current$66.89
Target$72.90
Return+9.0%
Nov 1, 2026

BrightSpring benefits from expanding specialty pharmacy demand, growing home-health operations, and improving cash generation, although reimbursement exposure and demanding earnings expectations limit its margin of safety.

Score
72
Lincoln Electric Holdings, Inc.
LECO·Industrials
B ★★★Hold
Current$276.92
Target$294.17
Return+6.2%
Nov 1, 2026

Lincoln Electric combines leading welding technology, recurring consumables demand, and exceptional capital efficiency with growing automation opportunities, but its premium valuation leaves limited protection against an industrial slowdown.

Score
73
Enterprise Products Partners L.P.
EPD·Energy
B ★★★Hold
Current$38.15
Target$42.00
Return+10.1%
Nov 1, 2026

Enterprise offers durable midstream cash flows, strong distribution coverage and growing natural gas infrastructure demand, but its historically elevated valuation and capital-intensive expansion limit near-term upside.

Score
72
DT Midstream, Inc.
DTM·Energy
B ★★★Hold
Current$124.34
Target$135.38
Return+8.9%
Nov 1, 2026

DT Midstream offers durable contracted natural gas infrastructure cash flows and growth from power demand, but elevated valuation and capital-intensive expansion limit its margin of safety.

Score
65
Blue Owl Capital Inc.
OWL·Financials
B ★★★Hold
Current$10.33
Target$12.48
Return+20.8%
Nov 1, 2026

Blue Owl's recurring private-market fees, growing AUM, and high dividend yield offer an attractive long-term income-and-growth opportunity, but private-credit risks, substantial equity compensation, and dilution threaten per-share returns.

Score
74
WESCO International, Inc.
WCC·Industrials
B ★★★Hold
Current$343.11
Target$378.00
Return+10.2%
Nov 1, 2026

WESCO combines expanding data center infrastructure demand with improving distribution margins and a record backlog, but its elevated historical valuation and working-capital intensity limit the margin of safety.

Score
68
Allegro MicroSystems, Inc.
ALGM·Technology
B ★★★Hold
Current$30.53
Target$37.20
Return+21.8%
Nov 1, 2026

Allegro MicroSystems can benefit from expanding demand for specialized sensing and power semiconductors, but cyclical automotive exposure, intense competition, and demanding cash-flow valuation limit its margin of safety.

Score
70
Madison Air Solutions Corporation
MAIR·Industrials
B ★★★Hold
Current$23.16
Target$28.80
Return+24.4%
Nov 1, 2026

Madison Air benefits from structural demand for advanced cooling and engineered air quality products, supported by a large commercial backlog, but acquisition-related dilution, leverage, and integration risks constrain near-term shareholder returns.

Score
68
California Water Service Group
CWT·Utilities
B ★★★Hold
Current$48.50
Target$52.00
Return+7.2%
Nov 1, 2026

California Water Service combines protected water utility franchises, recurring dividends, and regulated rate-base growth with a relatively low historical book-value multiple, but heavy capital spending and financing costs constrain per-share returns.

Score
74
Columbia Sportswear Company
COLM·Consumer Discretionary
B ★★★Hold
Current$67.54
Target$72.00
Return+6.6%
Nov 1, 2026

Columbia Sportswear combines established outdoor brands, improving profitability, and meaningful shareholder returns at a reasonable valuation, but weak organic growth, tariff exposure, and inventory risks limit near-term upside.

Score
73